Orthogon Therapeutics Funding & Investors
Braintree, MA
Orthogon Therapeutics is a preclinical-stage drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets. It focuses on the development of antiviral drugs for immune-suppressed patients.
orthogontherapeutics.comTotal Amount Raised: $23,600,000
Orthogon Therapeutics Funding Rounds
Series Unknown
$5,200,000
Series Unknown
$6,000,000
Series B
$8,000,000
Series A
$4,400,000
Series A Investors
Over-the-Rhine FoundationHolbrook Angels of Boston
Funding info provided by Diffbot.